Skip to main content
Erschienen in: Clinical Rheumatology 11/2020

06.05.2020 | Original Article

Role of serum leptin levels and leptin receptor gene polymorphisms in systemic lupus erythematosus

verfasst von: Abd EL-Moaty Ali Afifi, Reham M. Shaat, Ola Mohamed Gharbia, M. Elhanafy, Al Shimaa Goda Hasan

Erschienen in: Clinical Rheumatology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Serum leptin and leptin receptor gene polymorphisms may play a role in the etiopathogenesis of SLE.

Objective

This study was undertaken to explore the relationship between serum leptin levels and leptin receptor (LEPR) gene polymorphisms with susceptibility to SLE in Egyptian population and to study their relationships with clinical, laboratory, radiographic findings, and disease activity of SLE (SLEDAI).

Materials and methods

A total of 50 unrelated female patients, who met the SLICC classification criteria for SLE and fifty healthy blood donors, matched for age, sex, and BMI with SLE patients, serving as a control group, were included in this study. All participants had completed preliminary questionnaires and clinical, laboratory, and radiographic examinations. Serum leptin levels were measured by ELISA assays. LEPR genotyping was done by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method. We compared serum leptin levels and LEPR gene polymorphisms in SLE patients and controls, and we tested their relationships with clinical, laboratory, and radiographic findings and SLEDAI in SLE patients.

Results

The present study showed significant differences of serum leptin levels between SLE patients and controls (p < 0.001). Moreover, higher frequencies of variant genotype (AA) and (A) allele were found in SLE patients compared to controls (p = 0.008 and 0.001, respectively). No associations were observed between the serum leptin, various LEPR genotypes, and gene alleles and the development of clinical, laboratory, and radiological manifestations. Furthermore, no associations were observed between the various LEPR genotypes or gene alleles and leptin levels (p = 0.633 and 0.337 respectively) in SLE patients. Additionally, no correlations were observed between leptin levels, various genotypes, and alleles with SLEDAI (p = 0.244, 0.741, and 0.838 respectively) in SLE patients.

Conclusion

Serum leptin and LEPR gene polymorphism increase risk of SLE in Egyptian population; however, they are not associated with the development of clinical, lab, and radiological findings. Disease activity is neither correlated with serum leptin level nor associated with LEPR gene polymorphism. Serum levels of leptin are not associated with LEPR gene polymorphism.
Key Points
Serum leptin and LEPR gene polymorphism increase risk of SLE in Egyptian patients.
Serum leptin is not associated with SLE disease activity.
Literatur
1.
Zurück zum Zitat Li H, Zhang T, Leng R, Li X, Li X, Pan H (2015) Plasma/serum leptin levels in patients with systemic lupus erythemaosus: a meta-analysis. Arch Med Res 46:551–556CrossRef Li H, Zhang T, Leng R, Li X, Li X, Pan H (2015) Plasma/serum leptin levels in patients with systemic lupus erythemaosus: a meta-analysis. Arch Med Res 46:551–556CrossRef
2.
Zurück zum Zitat Tsokos G (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121CrossRef Tsokos G (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121CrossRef
3.
Zurück zum Zitat La Cava A (2016) Leptin-related polymorphisms and SLE. Inflamm Cell Signal 3:e1171 La Cava A (2016) Leptin-related polymorphisms and SLE. Inflamm Cell Signal 3:e1171
4.
Zurück zum Zitat Jeganathan V, Peeva E, Diamond B (2014) Hormonal milieu at time of B cell activation controls duration of autoantibody response. J Autoimmun 53:46–54CrossRef Jeganathan V, Peeva E, Diamond B (2014) Hormonal milieu at time of B cell activation controls duration of autoantibody response. J Autoimmun 53:46–54CrossRef
5.
Zurück zum Zitat La Cava A, Matarese G (2004) The weight of leptin in immunity. Nat Rev Immunol 4:371–379CrossRef La Cava A, Matarese G (2004) The weight of leptin in immunity. Nat Rev Immunol 4:371–379CrossRef
6.
Zurück zum Zitat Montague C, Farooqi I, Whitehead J, Soos M, Rau H, Wareham N et al (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908CrossRef Montague C, Farooqi I, Whitehead J, Soos M, Rau H, Wareham N et al (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908CrossRef
7.
Zurück zum Zitat Mantzoros C, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno T, Kim SY et al (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567–E584CrossRef Mantzoros C, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno T, Kim SY et al (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567–E584CrossRef
8.
Zurück zum Zitat Procaccini C, Jirillo E, Matarese G (2012) Leptin as an immunomodulator. Mol Asp Med 33:35–45CrossRef Procaccini C, Jirillo E, Matarese G (2012) Leptin as an immunomodulator. Mol Asp Med 33:35–45CrossRef
9.
Zurück zum Zitat Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediat Inflamm 568343 Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediat Inflamm 568343
10.
Zurück zum Zitat Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Obesity Society et al (2014) 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 63(25 Pt B):2985–3023CrossRef Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Obesity Society et al (2014) 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 63(25 Pt B):2985–3023CrossRef
11.
Zurück zum Zitat Amarilyo G, Iikuni N, Shi F, Liu A, Matarese G, La Cava A (2013) Leptin promotes lupus T-cell autoimmunity. Clin Immunol 149:530–533CrossRef Amarilyo G, Iikuni N, Shi F, Liu A, Matarese G, La Cava A (2013) Leptin promotes lupus T-cell autoimmunity. Clin Immunol 149:530–533CrossRef
12.
Zurück zum Zitat Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H (2014) Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J Immunol 192:979–984CrossRef Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H (2014) Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J Immunol 192:979–984CrossRef
13.
Zurück zum Zitat Stofkova A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43:157–168PubMed Stofkova A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43:157–168PubMed
14.
Zurück zum Zitat Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC, Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, la Cava A (2015) Genetic associations of leptin-r elated polymorphisms with systemic lupus erythematosus. Clin Immunol 161:157–162CrossRef Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC, Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, la Cava A (2015) Genetic associations of leptin-r elated polymorphisms with systemic lupus erythematosus. Clin Immunol 161:157–162CrossRef
15.
Zurück zum Zitat Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86:4434–4439CrossRef Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86:4434–4439CrossRef
16.
Zurück zum Zitat Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, Makino H (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33:1545–1552PubMed Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, Makino H (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33:1545–1552PubMed
17.
Zurück zum Zitat Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH (2010) Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 19:170–174CrossRef Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH (2010) Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 19:170–174CrossRef
18.
Zurück zum Zitat Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, Martínez-Abundis E, Gamez-Nava JI (2002) Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 22:138–141CrossRef Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, Martínez-Abundis E, Gamez-Nava JI (2002) Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 22:138–141CrossRef
19.
Zurück zum Zitat McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chernishof M, Gorn A, Witztum JL, Wong WK, Weisman M, Wallace DJ, la Cava A, Hahn BH (2011) High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 70(9):1619–1624CrossRef McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chernishof M, Gorn A, Witztum JL, Wong WK, Weisman M, Wallace DJ, la Cava A, Hahn BH (2011) High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 70(9):1619–1624CrossRef
20.
Zurück zum Zitat Lee YH, Nath SK (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118:434–443CrossRef Lee YH, Nath SK (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118:434–443CrossRef
21.
Zurück zum Zitat Bentham J, Vyse TJ (2013) The development of genome-wide association studies and their application to complex diseases, including lupus. Lupus 22:1205–1213CrossRef Bentham J, Vyse TJ (2013) The development of genome-wide association studies and their application to complex diseases, including lupus. Lupus 22:1205–1213CrossRef
22.
Zurück zum Zitat Afroze D, Yousuf A, Ali R, Kawoosa F, Akhtar T, Reshi S, Shah ZA (2015) Serum leptin levels, leptin receptor gene (LEPR) polymorphism, and the risk of systemic lupus erythematosus in Kashmiri population. Immunol Investig 44:113–125CrossRef Afroze D, Yousuf A, Ali R, Kawoosa F, Akhtar T, Reshi S, Shah ZA (2015) Serum leptin levels, leptin receptor gene (LEPR) polymorphism, and the risk of systemic lupus erythematosus in Kashmiri population. Immunol Investig 44:113–125CrossRef
23.
Zurück zum Zitat Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686CrossRef Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686CrossRef
24.
Zurück zum Zitat Li HM, Zhang TP, Leng RX, Li XP, Wang DG, Li XM, Ye DQ, Pan HF (2017) Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population. J Cell Mol Med 21(9):1732–1741CrossRef Li HM, Zhang TP, Leng RX, Li XP, Wang DG, Li XM, Ye DQ, Pan HF (2017) Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population. J Cell Mol Med 21(9):1732–1741CrossRef
25.
Zurück zum Zitat Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M et al (1992) Disease activity in systemic lupus erythematosus: report of the consensus study Group of the European Workshop for rheumatology research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10(5):549–554PubMed Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M et al (1992) Disease activity in systemic lupus erythematosus: report of the consensus study Group of the European Workshop for rheumatology research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10(5):549–554PubMed
26.
Zurück zum Zitat La Cava A, Alviggi C, Matarese G (2004) Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (Berl) 82(1):4–11CrossRef La Cava A, Alviggi C, Matarese G (2004) Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (Berl) 82(1):4–11CrossRef
27.
Zurück zum Zitat Al M, Ng L, Tyrrell P, Bradley T, Silverman E (2009) Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology 48:497–501CrossRef Al M, Ng L, Tyrrell P, Bradley T, Silverman E (2009) Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology 48:497–501CrossRef
28.
Zurück zum Zitat Vadacca M, Zardi EM, Margiotta D, Rigon A, Cacciapaglia F, Arcarese L, Buzzulini F, Amoroso A, Afeltra A (2013) Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus. Intern Emerg Med 8:705–712CrossRef Vadacca M, Zardi EM, Margiotta D, Rigon A, Cacciapaglia F, Arcarese L, Buzzulini F, Amoroso A, Afeltra A (2013) Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus. Intern Emerg Med 8:705–712CrossRef
29.
Zurück zum Zitat Ma L, Li D, Sookha MR, Fang M, Guan Y, Sun X, Guan J (2015) Elevated serum leptin levels in patients with systemic lupus erythematosus. Pharmazie 70:720–723PubMed Ma L, Li D, Sookha MR, Fang M, Guan Y, Sun X, Guan J (2015) Elevated serum leptin levels in patients with systemic lupus erythematosus. Pharmazie 70:720–723PubMed
30.
Zurück zum Zitat Margiotta D, Navarini L, Vadacca M, Basta F, Lo Vullo M, Pignataro F, Zardi EM, Afeltra A (2016) Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. Eur Rev Med Pharmacol Sci 20:636–641PubMed Margiotta D, Navarini L, Vadacca M, Basta F, Lo Vullo M, Pignataro F, Zardi EM, Afeltra A (2016) Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. Eur Rev Med Pharmacol Sci 20:636–641PubMed
31.
Zurück zum Zitat Wang LH, Liu YC, Wang JH, Lee CJ, Hsu BG (2017) Serum leptin level positively correlates with metabolic syndrome among elderly Taiwanese. Ci Ji Yi Xue Za Zhi 29(3):159–164PubMed Wang LH, Liu YC, Wang JH, Lee CJ, Hsu BG (2017) Serum leptin level positively correlates with metabolic syndrome among elderly Taiwanese. Ci Ji Yi Xue Za Zhi 29(3):159–164PubMed
32.
Zurück zum Zitat Lee YH, Song GG (2018) Association between circulating leptin levels and systemic lupus erythematosus: an updated meta-analysis. Lupus 27(3):428–435CrossRef Lee YH, Song GG (2018) Association between circulating leptin levels and systemic lupus erythematosus: an updated meta-analysis. Lupus 27(3):428–435CrossRef
33.
Zurück zum Zitat Wisłowska M, Rok M, Stepień K, Kuklo-Kowalska A (2008) Serum leptin in systemic lupus erythematosus. Rheumatol Int 28:467–473CrossRef Wisłowska M, Rok M, Stepień K, Kuklo-Kowalska A (2008) Serum leptin in systemic lupus erythematosus. Rheumatol Int 28:467–473CrossRef
34.
Zurück zum Zitat Li HM, Zhang TP, Leng RX, Li XP, Li XM, Pan HF (2015) Plasma/serum leptin levels in patients with systemic lupus erythematosus: a meta-analysis. Arch Med Res 46:551–556CrossRef Li HM, Zhang TP, Leng RX, Li XP, Li XM, Pan HF (2015) Plasma/serum leptin levels in patients with systemic lupus erythematosus: a meta-analysis. Arch Med Res 46:551–556CrossRef
35.
Zurück zum Zitat De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4):272–274CrossRef De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4):272–274CrossRef
36.
Zurück zum Zitat Méndez-Sánchez N, Bermejo-Martínez L, Chávez-Tapia NC, Zamora-Valdés D, Sánchez-Lara K, Uribe-Ramos MH, Ponciano-Rodríguez G, Baptista-González HA, Ramos MH, Uribe M (2006) Obesity-related leptin receptor polymorphisms and gallstones disease. Ann Hepatol 5:97–102CrossRef Méndez-Sánchez N, Bermejo-Martínez L, Chávez-Tapia NC, Zamora-Valdés D, Sánchez-Lara K, Uribe-Ramos MH, Ponciano-Rodríguez G, Baptista-González HA, Ramos MH, Uribe M (2006) Obesity-related leptin receptor polymorphisms and gallstones disease. Ann Hepatol 5:97–102CrossRef
37.
Zurück zum Zitat Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Potter JD (2007) Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomark Prev 16:2697–2703CrossRef Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Potter JD (2007) Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomark Prev 16:2697–2703CrossRef
38.
Zurück zum Zitat Khatoon K, Arkani M, Safaei A (2011) Association of leptin receptor gene Gln223Arg polymorphism with susceptibility to colorectal cancer. Gastroenterol Hepatol Bed Bench 4:92–198 Khatoon K, Arkani M, Safaei A (2011) Association of leptin receptor gene Gln223Arg polymorphism with susceptibility to colorectal cancer. Gastroenterol Hepatol Bed Bench 4:92–198
39.
Zurück zum Zitat Carrillo-Vazquez JP, Lopez-Alcantar J, Chimal-Vega B et al (2013) G-2548A Lepin promoter and Q223R lepin receptor polymorphism in obese Mexican subjects. Am J Agric Biol Sci 8(1):34–43CrossRef Carrillo-Vazquez JP, Lopez-Alcantar J, Chimal-Vega B et al (2013) G-2548A Lepin promoter and Q223R lepin receptor polymorphism in obese Mexican subjects. Am J Agric Biol Sci 8(1):34–43CrossRef
40.
Zurück zum Zitat Barbosa VDS, Francescantônio PL, Silva NAD (2015) Leptina e adiponectina no lúpus eritematoso sistêmico: correlações clínicas e laboratoriais. Rev Bras Reumatol 55:140–145CrossRef Barbosa VDS, Francescantônio PL, Silva NAD (2015) Leptina e adiponectina no lúpus eritematoso sistêmico: correlações clínicas e laboratoriais. Rev Bras Reumatol 55:140–145CrossRef
Metadaten
Titel
Role of serum leptin levels and leptin receptor gene polymorphisms in systemic lupus erythematosus
verfasst von
Abd EL-Moaty Ali Afifi
Reham M. Shaat
Ola Mohamed Gharbia
M. Elhanafy
Al Shimaa Goda Hasan
Publikationsdatum
06.05.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 11/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05120-5

Weitere Artikel der Ausgabe 11/2020

Clinical Rheumatology 11/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.